Battelle Hosts National Security Commission on Emerging Biotechnology to Highlight Ohio’s Growing Biotechnology Capabilities Battelle recently welcomed members of the National Security Commission on Emerging Biotechnology (NSCEB) to its Columbus,…
AIDS Healthcare Foundation Supports Bipartisan SUSTAIN 340B Act to Strengthen and Protect Federal Drug Discount Program AIDS Healthcare Foundation (AHF) has welcomed the introduction of draft bipartisan legislation in the…
Multicenter Study Demonstrates Superior Outcomes with equicenta® CTM for Returning Performance Horses to Work Equine Performance Labs (EPL), the company behind equicenta® CTM, has announced the publication of new peer-reviewed…
Diabetes and Metabolism Specialists Improves Patient Engagement and Chronic Care Management with eClinicalWorks Digital Solutions eClinicalWorks®, a leading ambulatory cloud electronic health record (EHR) provider, announced that Diabetes and Metabolism…
City of Hope Study Shows Education Program Can Dramatically Improve Skin Cancer Screening Among Hematopoietic Cell Transplant Survivors Experts at City of Hope®, one of the nation’s leading cancer research…
LabPMM Launches Global KMT2A Measurable Residual Disease Testing Service to Advance Precision Monitoring in Acute Leukemia LabPMM®, a subsidiary of Invivoscribe®, has announced the worldwide launch of its new KMT2A…
Clinilabs Strengthens Executive Leadership with the Appointments of Dr. Bob Dagher as Chief Medical Officer and Dr. Waqar Ahmed Siddiqui as Principal Investigator Clinilabs LLC, a global full-service contract research…
Helen Branswell Named Recipient of the 2026 Kovler Prize for Trust in Life Science Journalism The Foundation for the National Institutes of Health (FNIH) has announced that renowned infectious disease…
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Neuroplastogenic Candidate EB-003 Enveric Biosciences, a clinical-stage biotechnology company focused on developing next-generation neuroplastogenic small-molecule therapies for psychiatric…
Expedition Therapeutics Raises Oversubscribed $115 Million Series B Financing and Advances EXPD-101 into Phase 2 Clinical Trial for COPD Expedition Therapeutics, a clinical-stage biotechnology company focused on developing innovative oral…
Synthekine Appoints Biotechnology Veteran Dr. Susan M. Molineaux as CEO to Lead Next Phase of Oncology Drug Development Synthekine, Inc., a clinical-stage biotechnology company focused on developing precision cytokine therapeutics…
ZAP Surgical Expands Presence in China with New ZAP-X Radiosurgery Installation at Changchun Tumor Hospital ZAP Surgical Systems, Inc., a global innovator in non-invasive robotic brain surgery technologies, has announced…